Patents by Inventor Matthias Lechmann

Matthias Lechmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
    Patent number: 9732140
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: August 15, 2017
    Assignee: ARGOS THERAPEUTICS, INC.
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
    Patent number: 9102726
    Abstract: The present invention provides methods of using soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 proteins, specifically suited for said purpose, nucleic acids and vectors encoding said CD83 proteins, cells transformed/transfected with the nucleic acids or vectors, methods for producing said CD83 proteins, pharmaceutical compositions containing said CD83 proteins, nucleic acids or vectors, and antibodies against said soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: August 11, 2015
    Assignee: ARGOS THERAPEUTICS, INC.
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • USE OF SOLUBLE FORMS OF CD83 AND NUCLEIC ACIDS ENCODING THEM FOR THE TREATMENT OR PREVENTION OF DISEASES
    Publication number: 20150065684
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: June 17, 2014
    Publication date: March 5, 2015
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: ALEXANDER STEINKASSERER, MATTHIAS LECHMANN, ELISABETH ZINSER
  • Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
    Patent number: 8759505
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: June 24, 2014
    Assignee: Argos Therapeutics, Inc.
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
    Patent number: 8124099
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: February 28, 2012
    Assignee: Argos Therapeutics, Inc.
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases
    Publication number: 20120015890
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: January 21, 2011
    Publication date: January 19, 2012
    Applicant: ARGOS THERAPEUTICS, INC.
    Inventors: Alexander STEINKASSERER, Matthias Lechmann, Elisabeth Zinser
  • Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
    Patent number: 7893200
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: February 22, 2011
    Assignee: Argos Therapeutics, Inc.
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elizabeth Zinser
  • Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
    Publication number: 20070212370
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: January 30, 2007
    Publication date: September 13, 2007
    Applicant: ARGOS THERAPEUTICS INC
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
    Publication number: 20070167607
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: November 19, 2003
    Publication date: July 19, 2007
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
    Patent number: 7169898
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: January 30, 2007
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
    Publication number: 20040116338
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: December 4, 2002
    Publication date: June 17, 2004
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser
  • Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
    Publication number: 20040110673
    Abstract: The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving T cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
    Type: Application
    Filed: March 6, 2003
    Publication date: June 10, 2004
    Inventors: Alexander Steinkasserer, Matthias Lechmann, Elisabeth Zinser